Evidence map›Paper›PMID 38361745›Full record

ReviewThe World Allergy Organization journal2024

Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee.

Paul J Turner, Ignacio J Ansotegui, Dianne E Campbell, Victoria Cardona, Stuart Carr, Adnan Custovic, Stephen Durham, Motohiro Ebisawa, Mario Geller, Alexei Gonzalez-Estrada and 16 more

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in The World Allergy Organization journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
17.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07764159 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

An Open-Label, Multicenter, Randomized Clinical Trial Evaluating the Efficacy and Safety of Oral Multi-Food Immunotherapy With Peanut and Tree Nuts Protein Mixtures

TypeinterventionalSponsorMedical University of WarsawRan2026 to 2031Enrolled39ConditionsFood Allergies, Food Allergy in Children, Peanut Allergies, Tree Nut AllergiesArmsMulti-Food Oral Immunotherapy (Multi-OIT) with Peanut and Tree Nuts Proteins, Standard of Care (Elimination Diet)
NCT07768696 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Oral Immunotherapy for Children With Cow's Milk Allergy: A Randomized Controlled Trial

TypeinterventionalSponsorLaura Ozer KettnerRan2026 to 2031Enrolled56ConditionsMilk Allergy, Cow's, Food Allergy in Children, Food AllergiesArmsOral immunotherapy with cow's milk
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Comparative safety analysis of coseasonal versus preseasonal Artemisia annua sublingual immunotherapy for allergic rhinitis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Triggers, clinical spectra and outcomes of pediatric anaphylaxis in a tertiary center: impact of comorbidities and cofactors on severity.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2026
    Article
  13. Review
  14. Article
  15. Anaphylaxis: Clinical Criteria, Severity, and Clinical Courses.Immunology and allergy clinics of North America · 2026
    Review
  16. Review
  17. Review
  18. Article
  19. Outcome Predictors of Oral Food Challenge in Children.Children (Basel, Switzerland) · 2026
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 20 institutions in 17 countries.

Paul J TurnerNational Heart Lung Institute, Imperial College London, London, UK.
Ignacio J AnsoteguiDept. Allergy and Immunology, Hospital Quironsalud Bizkaia, Bilbao, Spain.
Dianne E CampbellDiscipline of Paediatrics and Child Health, School of Medicine, University of Sydney, Sydney, Australia.
Victoria CardonaAllergy Section, Department of Internal Medicine, Hospital Vall d'Hebron, Barcelona, Spain.
Stuart CarrSnö Asthma & Allergy, Abu Dhabi, United Arab Emirates.
Adnan CustovicNational Heart Lung Institute, Imperial College London, London, UK.
Stephen DurhamNational Heart Lung Institute, Imperial College London, London, UK.
Motohiro EbisawaDepartment of Allergy, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.
Mario GellerDivision of Medicine, Academy of Medicine of Rio de Janeiro, Rio de Janeiro, Brazil.
Alexei Gonzalez-EstradaDivision of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA.
Paul A GreenbergerDivision of Allergy-Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Elham HossnyPediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt.
Carla IraniHotel Dieu de France Hospital, St Joseph University, Beirut, Lebanon.
Agnes S Y LeungDepartment of Paediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Michael E LevinDivision of Paediatric Allergy, Department of Paediatrics, University of Cape Town, Cape Town, South Africa.
Antonella MuraroDepartment of Woman and Child Health, Food Allergy Referral Centre, Padua University Hospital, Padua, Italy.
John J OppenheimerRutgers New Jersey Medical School, Atlantic Health System Morristown, NJ, USA.
José Antonio Ortega MartellUniversidad Autónoma del Estado de Hidalgo, Hidalgo, Mexico.
Guillaume PouesselDepartment of Paediatrics, Children's Hospital, Roubaix, France.
Manuel J RialAllergy department, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Gianenrico SennaAsthma Center and Allergy Unit, Verona University and General Hospital, Verona, Italy.
Luciana K TannoHospital Sírio Libanês, São Paulo, Brazil.
Dana V WallaceNova Southeastern University College of Allopathic Medicine, Fort Lauderdale, FL, USA.
Margitta WormDepartment of Dermatology and Allergology, Charite-Universitätsmedizin, Berlin, Germany.
Mário Morais-AlmeidaAllergy Center, CUF Descobertas Hospital, Lisbon, Portugal.
WAO Anaphylaxis Committee and WAO Allergen Immunotherapy Committee
Imperial College London · GBAbu Dhabi National Oil (United Arab Emirates) · AEAin Shams University Hospital · EGBrazilian Academy of Sciences · BRCentre Hospitalier Universitaire de Lille · FRCharité - Universitätsmedizin Berlin · DEChinese University of Hong Kong · HKComplexo Hospitalario Universitario A Coruña · ESCUF Porto Hospital · PTHospital Quirónsalud Barcelona · ESNational Sagamihara Hospital · JPNorthwestern University · USNova Southeastern University · USRutgers, The State University of New Jersey · USSaint Joseph University · LBSorbonne Université · FRThe University of Sydney · AUUniversidad Autónoma del Estado de Hidalgo · MXUniversity of Cape Town · ZAUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a lack of consensus over the description and severity assignment of allergic adverse reactions to immunotherapy, although there seems to be a consensus at least in terms of using the World Allergy Organization (WAO) grading systems to describe local adverse events for Sublingual Immunotherapy (SLIT) and Systemic Allergic Reactions (SARs) to Subcutaneous Immunotherapy (SCIT) amongst the major national/regional allergy societies. In this manuscript, we propose a modification of the previous WAO Grading system for SARs, which aligns with the newly-proposed Consortium for Food Allergy Research (CoFAR) Grading Scale for Systemic Allergic Reactions in Food Allergy (version 3.0). We hope this can facilitate a unified grading system appropriate to SARs due to allergen immunotherapy, independent of allergen and route of administration, and across clinical and research practice.

Indexed as

Adverse eventsAllergen immunotherapyAnaphylaxisClinical trialsSafety reporting

Identifiers

PMID38361745
PMCPMC10867340
OpenAlexW4391731174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.